Share
Corporation
Name |
Kunzite Cerebellum |
Ticker |
DR.SP |
Alliance |
- |
Faction |
- |
Ceo |
Dr Spodumain |
Members |
2 |
URL |
https://lab.isk.enterprises |
Tax Rate |
4% |
corporationID |
98647860 |
Members [2]
Description
u"A Gallente psychiatrist first developed a procedure that involved accessing the frontal lobes through the eye sockets, which would inspire Dr. Spodumain to develop the Kunzite Cerebellum Infusion procedure in YC117, a method that would not require a traditional surgeon and operating room. The technique involved using an instrument called an anthrakor\xfdchos, a modified mining laser, which the physician would insert through the patient's eye socket using a surgical mallet. They would then move the instrument side-to-side to separate the frontal lobes from the thalamus, the part of the brain that receives and relays sensory input. Once the cerebellum is exposed, a kunzite solution is introduced via the unoccupied eye socket, and any instruments removed. A successful procedure should leave no physical trace, but immediate psychological adaption in the patient."
Sovereignty systems [0]
The corporation doesn't hold any systems.
Last Update: 2024-11-24 19:16:42